Abstract

The Compatibility of Common Respiratory Therapy Drug Combinations

Author(s): Owsley Heather D, Rusho William F

Issue: Mar/Apr 1997 - Pediatric Care

Page(s): 121-122

Download in electronic PDF format for $75
  • The Compatibility of Common Respiratory Therapy Drug Combinations Page 1
  • The Compatibility of Common Respiratory Therapy Drug Combinations Page 2

Abstract

Respiratory therapists are being asked to take care of sicker patients and in many cases this requires the administration of multiple inhalation drugs. In an effort to reduce the workload, therapists are combining drugs in the same nebulizer. Pharmacists also are being asked to prepare unit dose preparations of combined inhalation drugs without physical compatibility data. It is theorized that some drug combinations precipitate and that these particulates are ultimately inhaled into the patient’s lungs. These particulates can cause locally high concentrations of drug resulting in tissue irritation or actual occlusion of the airway. This study tested the physical compatibility of 22 common combinations used in our hospital and found 19 of these combinations incompatible. Due to the potential of precipitation,we recommend that inhalation drugs not be routinely combined without specific compatibility data.

Related Keywords

  • Respiratory therapy, drug combinations, incompatibility of
  • Respiratory therapy, precipitation of drugs in

Related Categories

  • PEER-REVIEWED
  • STABILITIES, COMPATIBILITIES

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 1997
Pg. 121-122
The Compatibility of Common Respiratory Therapy Drug Combinations
Author(s): Owsley Heather D, Rusho William F
Jan/Feb 2020
Pg. 30-36
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Author(s): Dillon L R
May/Jun 2006
Pg. 175-183
The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States
Author(s): Stephenson Kenna, Jones William, Stephenson Douglas M M
Sep/Oct 2015
Pg. 357-365
Novel Approaches to Topical Psoriasis Therapy
Author(s): Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Sep/Oct 2003
Pg. 364-365
Technology Spotlight: Respiratory Vial Sealers
Author(s): Allen Loyd V Jr
May/Jun 2016
Pg. 202-206
Does Your Drug Expertise Include Clinical Pharmaceutics?
Author(s): Newton David W
Sep/Oct 2017
Pg. 356
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Author(s): Allen Loyd V Jr
May/Jun 2007
Pg. 200
Case Report: Ketoprofen/Riboflavin/Caffeine Capsules and Progesterone Therapy for Recurrent Migraine Pain
Author(s): Fields Shannon W
Sep/Oct 2007
Pg. 416
Acetaminophen 500-mg and Diphenhydramine Hydrochloride 25-mg Hot Therapy Packs
Author(s): Allen Loyd V Jr
Jan/Feb 2020
Pg. 44-50
Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved
Author(s): Allen Loyd V Jr
May/Jun 2013
Pg. 254-261
Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline
Author(s): Klemmer Anja, Krämer Irene, Kamin Wolfgang
Nov/Dec 2011
Pg. 526-527
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse
Author(s): Williams LaVonn A
Jan/Feb 2007
Pg. 56-58
Collaborative Drug Therapy Management and its Application to Pharmaceutical Compounding
Author(s): Anderson Derick
Jul/Aug 2003
Pg. 250-256
A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1
Author(s): Gillson George R, Zava David T
Mar/Apr 2011
Pg. 92
PreScription: Discontinued Drugs and Drug Shortages
Author(s): Allen Loyd V Jr
Jul/Aug 2012
Pg. 294-298
Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers
Author(s): Allen Loyd V Jr, Williams LaVonn A
Nov/Dec 2012
Pg. 456-460
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis
Author(s): Lyon Joanna
Jul/Aug 2016
Pg. 351
View Sample
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Author(s): Allen Loyd V Jr
Jul/Aug 2022
Pg. 298-301
The Role of Compounding Pharmacists During Drug Shortages
Author(s): Ofei Kelvin
Sep/Oct 2016
Pg. 359-364
Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1
Author(s): Deleruyelle Laura J